An intense higher-dose radiotherapy regimen may be a better treatment option for men with localized prostate cancer, according to the 10-year results of the international phase III RT01 trial.
The anti-programmed death 1 (PD-1) drug nivolumab may increase overall survival in patients with advanced melanoma with a safe and acceptable long-term safety profile, according to the results of a recent study.
The results of a retrospective study indicated that patients with metastatic GIST who are able to achieve complete macroscopic surgical resection of their disease may be able to achieve long-term survival.
A recent exploratory study found that GIST cells showed unexpected sensitivity to certain kinds of chemotherapy drugs not typically associated with the diseases’ treatment.
The risk for burnout appears to rise in direct proportion to the number of hours oncologists spend on direct patient care, according to a recent survey by ASCO.
A breath test that looks for carbonyl volatile organic compounds could help distinguish between benign and malignant nodules, and be used as an adjunct to CT scans in lung cancer diagnosis.
A 50-year-old male is receiving capecitabine with concurrent radiation therapy for stage III rectal cancer. For the past 7 days, the patient has been taking ciprofloxacin for a urinary tract infection.
The FGF inhibitor dovitinib failed to improve progression-free survival outcomes as a third-line treatment for patients with metastatic renal cell carcinoma compared with sorafenib, according to the results of a new study.
